Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:2671-2678
Published online before print November 20, 2006, doi: 10.1161/CIRCULATIONAHA.106.635128
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
114/24/2671    most recent
CIRCULATIONAHA.106.635128v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daubeney, P. E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daubeney, P. E. F.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Congestive
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery

(Circulation. 2006;114:2671-2678.)
© 2006 American Heart Association, Inc.


Pediatric Cardiology

Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy

Results From a National Population-Based Study

Piers E. F. Daubeney, MBBS; Alan W. Nugent, MBBS; Patty Chondros, MSc; John B. Carlin, PhD; Steven D. Colan, MD; Michael Cheung, MB, ChB; Andrew M. Davis, MD; C.W. Chow, MD; Robert G. Weintraub, MBBS, on behalf of the National Australian Childhood Cardiomyopathy Study

From the Departments of Cardiology (P.E.F.D., A.W.N., M.C., A.M.D., R.G.W.) and Anatomic Pathology (C.W.C.), Royal Children’s Hospital, Melbourne, Australia; Clinical Epidemiology and Biostatistics Unit (P.C., J.B.C.), Murdoch Children’s Research Institute, Melbourne, Australia; Departments of General Practice (P.C.) and Paediatrics (J.B.C., C.W.C.), University of Melbourne, Melbourne, Australia; and Department of Cardiology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, Mass (S.D.C.).

Correspondence to Dr Robert Weintraub, Department of Cardiology, Royal Children’s Hospital, Flemington Rd, Parkville, VIC 3052, Australia. E-mail robert.weintraub{at}rch.org.au

Received April 20, 2006; revision received September 17, 2006; accepted October 11, 2006.

Background— Despite considerable mortality, population-based prognostic factors for childhood dilated cardiomyopathy are lacking.

Methods and Results— A population-based cohort study was undertaken of all children in Australia who presented with cardiomyopathy at age 0 to 10 years between January 1, 1987, and December 31, 1996. A single cardiologist analyzed all cardiac investigations, and a single pathologist analyzed histopathological material. There were 184 subjects with dilated cardiomyopathy. Positive viral identification or lymphocytic myocarditis was found in 30 (68.2%) of 44 cases with available early histology and 8 of 9 cases presenting with sudden death. Freedom from death or transplantation was 72% (95% CI, 65% to 78%) 1 year after presentation and 63% (95% CI, 55% to 70%) at 5 years. By proportional hazards regression analysis, risk factors for death or transplantation comprised age >5 years at presentation (hazard ratio 5.6, 95% CI, 2.6 to 12.0), familial dilated cardiomyopathy (hazard ratio, 2.9; 95% CI, 1.5 to 5.6), lower initial fractional shortening z score (hazard ratio per z-score unit, 0.75; 95% CI, 0.65 to 0.87), and failure to increase fractional shortening z score during follow-up (hazard ratio per unit increase, 0.68; 95% CI, 0.58 to 0.79). At follow-up, 78 (44.6%) of 175 cases diagnosed during life have no symptoms and are not taking any cardiac medication.

Conclusions— Early mortality is high in childhood dilated cardiomyopathy, but the clinical status of long-term survivors is good. This population-based study identifies children at risk of adverse events.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
M A Weber, M T Ashworth, R A Risdon, M Malone, M Burch, and N J Sebire
Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series
Arch. Dis. Child., July 1, 2008; 93(7): 594 - 598.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Maiya, I Sullivan, J Allgrove, R Yates, M Malone, C Brain, N Archer, Q Mok, P Daubeney, R Tulloh, et al.
Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure
Heart, May 1, 2008; 94(5): 581 - 584.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. A. Webber
New-Onset Heart Failure in Children in the Absence of Structural Congenital Heart Disease
Circulation, January 1, 2008; 117(1): 11 - 12.
[Full Text] [PDF]